The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Tau protein as a differential biomarker of tauopathies
Open accessAbstract
Microtubule-associated Tau proteins are the basic component of intraneuronal and glial inclusions observed in many neurological disorders, the so-called tauopathies. Many etiological factors, phosphorylation, splicing, and mutations, relate Tau proteins to neurodegeneration. Molecular analysis has revealed that hyperphosphorylation and abnormal phosphorylation might be one of the important events in the process leading to tau intracellular aggregation. Specific set of pathological tau proteins exhibiting a typical biochemical pattern, and a different regional and laminar distribution, could characterize five main classes of tauopathies. A direct correlation has been established between the regional brain distribution of tau pathology and clinical symptoms; for instance progressive involvement of neocortical areas is well correlated to the severity of dementia in Alzheimer's disease, overall suggesting that pathological tau proteins are reliable marker of the neurodegenerative process. Recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies. Overall, a better knowledge of the etiological factors responsible for the aggregation of tau proteins in brain diseases is essential for development of future differential diagnosis and therapeutic strategies. They would hopefully find their application against Alzheimer's disease but also in all neurological disorders for which a dysfunction of Tau biology has been identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–239 of 239
Saito, T., Ishiguro, K., Uchida, T., Miyamoto, E., Kishimoto, T., & Hisanaga, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01292-0 · Cited by 55
Russ, C., Powell, J. F., Zhao, J., Baker, M., Hutton, M., Crawford, F., Mullan, M., Roks, G., Cruts, M., & Lovestone, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02289-3 · Cited by 55
Microtubule-associated proteins and the determination of neuronal form.
Matus, A. I. (1990) · PubMed · Cited by 53
A novel tau‐tubulin kinase from bovine brain
Takahashi, M., Tomizawa, K., Sato, K., Ohtake, A., & Omori, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00955-9 · Cited by 53
Zhukareva, V. A., Sundarraj, S., Mann, D. M. A., Sjögren, M. J. C., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0668-8 · Cited by 52
Subpopulations of tau interact with microtubules and actin filaments in various cell types
Henríquez, J. P., Cross, D. C., Vial, C., & Maccioni, R. B. (1995) · Cell Biochemistry and Function · doi:10.1002/cbf.290130404 · Cited by 51
Singh, T. J., Zaidi, T., Grundke, I., & Iqbal, K. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00226782 · Cited by 51
Maurage, C., Sergeant, N., Schraen‐Maschke, S., Lebert, F., Ruchoux, M., Sablonnière, B., Pasquier, F., & Delacourte, A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0762-6 · Cited by 51
Self-citationMicrotubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation
Ingelson, M., Vanmechelen, E., & Lannfelt, L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13218-3 · Cited by 50
Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or TAU
Jung, D., Filliol, D., Miehe, M., & Rendón, Á. (1993) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970240405 · Cited by 49
Crawford, F., Freeman, M., Town, T., Fallin, D., Gold, M., Duara, R., & Mullan, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00303-1 · Cited by 49
Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins
Sergeant, N., Bussière, T., Vermersch, P., Lejeune, J. P., & Delacourte, A. (1995) · Neuroreport · doi:10.1097/00001756-199511000-00028 · Cited by 49
Self-citationA τ Promoter Region Without Neuronal Specificity
Andreadis, A., Wagner, B. K., Broderick, J. A., & Kosik, K. S. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062257.x · Cited by 47
Hof, P. R., Charpiot, A., Delacourte, A., Buée, L., Purohit, D. P., Perl, D. P., & Bouras, C. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90846-y · Cited by 45
Self-citationMutation screening of the tau gene in patients with early-onset Alzheimer's disease
Roks, G., Dermaut, B., Heutink, P., Julliams, A., Backhovens, H., den Broeck, M. V., Serneels, S., Albert Hofman, D., Broeckhoven, C. V., van Duijn, C. M., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00861-7 · Cited by 44
FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion
Yen, S. H., Easson, C., Nacharaju, P., Hutton, M. L., & Yen, S.-H. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01427-1 · Cited by 44
Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy.
Yoshimura, N., Otake, M., Igarashi, K., Matsunaga, M., Takebe, K., & Kudo, H. (1990) · PubMed · Cited by 44
Takahashi, M., Tomizawa, K., Ishiguro, K., Takamatsu, M., Fujita, S. C., & Imahori, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041759.x · Cited by 43
Multisite phosphorylation of τ proteins from rat brain
Pierre, M., & Nunez, J. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90991-9 · Cited by 43
Discodermolide interferes with the binding of tau protein to microtubules
Kar, S., Florence, G. J., Paterson, I., & Amos, L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00181-9 · Cited by 42
Athan, E. S., Lee, J. H., Arriaga, A., Mayeux, R. P., & Tycko, B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1793 · Cited by 41
Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation
Luo, M., Leski, M. L., & Andreadis, A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20029 · Cited by 37
Mattila, P. M., Togo, T., & Dickson, D. W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00006-x · Cited by 33
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
Spillantini, M. G., Van Swieten, J. C., & Goedert, M. (2000) · Neurogenetics · doi:10.1007/s100489900084 · Cited by 33
Clinical and Genetic Aspects of Progressive Supranuclear Palsy
Litvan, I., & Hutton, M. L. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100208 · Cited by 30
[Pick's disease. Anatomo-clinical point of view].
Brion, S., Plas, J., & Jeanneau, A. (1991) · PubMed · Cited by 29
Roder, H. M., Fracasso, R. P., Hoffman, F. J., Witowsky, J. A., Davis, G. L., & Pellegrino, C. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4509 · Cited by 24
Dudek, S. M., & Johnson, G. V. W. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(96)83486-9 · Cited by 23
O-GlcNAc Glycosylation and Neurological Disorders
Lefebvre, T., Caillet‐Boudin, M., Buée, L., Delacourte, A., & Michalski, J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0_12 · Cited by 22
Self-citationArgyrophilic grain disease: molecular genetic difference to other four-repeat tauopathies
Miserez, A. R., Clavaguera, F., Monsch, A. U., Probst, A., & Tolnay, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0742-x · Cited by 22
Molecular neuropathology of Alzheimer's disease:In situ hybridization studies
Goedert, M., & Spillantini, M. G. (1990) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733642 · Cited by 14
Advances in myotonic dystrophy: a clinical and genetic perspective.
Reardon, W., & Harper, P. S. (1992) · PubMed · Cited by 12
Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity
Soulié, C., Lepagnol, J. M., Delacourte, A., & Caillet‐Boudin, M. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12472-1 · Cited by 10
Self-citationRole for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Heart disease in myotonic dystrophy
Harper, P. S., & Reardon, W. (1992) · The Lancet · doi:10.1016/0140-6736(92)90989-g · Cited by 7
Alzheimer's neurofibrillary changes in the olfactory bulb in myotonic dystrophy.
Yoshimura, N. (1990) · PubMed · Cited by 6
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Complexité génétique de la maladie d’Alzheimer
Chartier‐Harlin, M., Goumidi, L., & Lambert, J. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)70899-1 · Cited by 2
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Šimić, G., Babić Leko, M., Wray, S., Harrington, C., Delalle, I., Jovanov-Milošević, N., Bažadona, D., Buée, L., De Silva, R., Di Giovanni, G., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 703
Self-citationTau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
Wang, C., & Holtzman, D. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0478-5 · Cited by 615
Metadata
- Authors
- Sergeant, N., Delacourte, A., & Buée, L.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 1739
- Issue
- 2-3
- Pages
- 179-197
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2114415876
- Cited by
- 313
- References
- 239
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.